Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

40 Years after the Registration of Acyclovir: Do We Need New Anti-Herpetic Drugs?
Anna Majewska, Beata Młynarczyk-Bonikowska
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3431-3431
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Selenization of Small Molecule Drugs: A New Player on the Board
Cristina Morán-Serradilla, Daniel Plano, Carmen Sanmartín, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7759-7787
Closed Access | Times Cited: 21
How We Diagnose and Manage Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infection After Hematopoietic Cell Transplantation
Tali Shafat, Ella J. Ariza Heredia, Marilyne Daher, et al.
Clinical Microbiology and Infection (2025)
Closed Access | Times Cited: 2
Alzheimer’s disease as a viral disease: Revisiting the infectious hypothesis
Francesco Bruno, Paolo Abondio, Rossella Bruno, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102068-102068
Open Access | Times Cited: 41
Refractory and Resistant Herpes Simplex Virus Mucocutaneous Infections in Immunocompromised Patients: Literature Review and Proposed Definitions for Use in Clinical Trials
Roy F. Chemaly, Tali Shafat, Anna Wald, et al.
Clinical Infectious Diseases (2025)
Open Access | Times Cited: 1
Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients
Daan W. Huntjens, Jacob A. Dijkstra, Lisanne N. Verwiel, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 163-163
Open Access | Times Cited: 21
Management of oral herpes simplex virus infections: The problem of resistance. A narrative review
Evangelia Piperi, E. Papadopoulou, Maria Georgaki, et al.
Oral Diseases (2023) Vol. 30, Iss. 3, pp. 877-894
Open Access | Times Cited: 20
Small Molecule Drugs Targeting Viral Polymerases
Deborah Palazzotti, Martina Sguilla, Giuseppe Manfroni, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 661-661
Open Access | Times Cited: 8
Neonatal herpes simplex virus infection: From the maternal infection to the child outcome
Domenico Umberto De Rose, Sarah Bompard, Chiara Maddaloni, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 8
Open Access | Times Cited: 12
Mechanism and significance of cell senescence induced by viral infection
Yunchuang Chang, Xinna Wu, Lingli Deng, et al.
Journal of Zhejiang University (Medical Sciences) (2025) Vol. 54, Iss. 1, pp. 70-80
Open Access
Simultaneous Monitoring of 3 Antiviral Drugs in Serum Using Liquid Chromatography–Tandem Mass Spectrometry: Full Validation and Clinical Application
L.C. Giraudo Conesa, Gonzalo Gonzalez-Silva, Lydia Peris-Serra, et al.
Therapeutic Drug Monitoring (2025)
Closed Access
The Antiviral Activity of Polyphenols
Markus Burkard, Alban Piotrowsky, Christian Leischner, et al.
Molecular Nutrition & Food Research (2025)
Open Access
Toward the Eradication of Herpes Simplex Virus: Vaccination and Beyond
Jane Chang, Curt Balch, Hyung Suk Oh
Viruses (2024) Vol. 16, Iss. 9, pp. 1476-1476
Open Access | Times Cited: 3
Insights into Antiviral Properties and Molecular Mechanisms of Non-Flavonoid Polyphenols against Human Herpesviruses
Sherif T. S. Hassan, Miroslava Šudomová, Alena Mazuráková, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13891-13891
Open Access | Times Cited: 15
Current Perspectives on the Management of Herpesvirus Infections in Solid Organ Transplant Recipients
S. Reshwan K. Malahe, Jeroen J. A. van Kampen, Olivier C. Manintveld, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1595-1595
Open Access | Times Cited: 8
Combined Treatment with Host-Directed and Anticytomegaloviral Kinase Inhibitors: Mechanisms, Synergisms and Drug Resistance Barriers
Markus Wild, Dubravka Karner, Jan Eickhoff, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2680-2680
Open Access | Times Cited: 8
In silico identification of novel drug target and its natural product inhibitors for herpes simplex virus
Prity Vinjoda, Saurav Kumar Mishra, Kanchan Sharma, et al.
Elsevier eBooks (2023), pp. 377-383
Closed Access | Times Cited: 7
Harmol used for the treatment of herpes simplex virus induced keratitis
Huanhuan Xu, Nan Zhou, Zhenping Huang, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
The antiherpetic and anti-inflammatory activity of the frog-derived peptide Hylin-a1
Annalisa Chianese, Rosa Giugliano, Francesca Palma, et al.
Journal of Applied Microbiology (2024) Vol. 135, Iss. 7
Closed Access | Times Cited: 2
Viral replication organelles: the highly complex and programmed replication machinery
Hao Deng, Hongwei Cao, Yanjin Wang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 2
Supportive care and antiviral treatments in primary herpetic gingivostomatitis: a systematic review
Noemi Coppola, Tiziana Cantile, Daniela Adamo, et al.
Clinical Oral Investigations (2023) Vol. 27, Iss. 11, pp. 6333-6344
Open Access | Times Cited: 6
Resistant herpes simplex virus infections – who, when, and what's new?
Benjamin D. Kotton, Camille N. Kotton
Current Opinion in Infectious Diseases (2022) Vol. 35, Iss. 6, pp. 530-535
Closed Access | Times Cited: 9
Combination Therapy for the Treatment of Shingles with an Immunostimulatory Vaccine Virus and Acyclovir
Tibor Bakács, Volker Sandig, Imre Kovesdi
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 226-226
Open Access | Times Cited: 5
Photodynamic Inhibition of Herpes Simplex Virus 1 Infection by Tricationic Amphiphilic Porphyrin with a Long Alkyl Chain
Igor Jurak, Maja Cokarić Brdovčak, Lara Djaković, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 956-956
Open Access | Times Cited: 5
Complete and Prolonged Inhibition of Herpes Simplex Virus Type 1 Infection In Vitro by CRISPR/Cas9 and CRISPR/CasX Systems
Dmitry S. Karpov, N. A. Demidova, Kirill A. Kulagin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14847-14847
Open Access | Times Cited: 8
Current scenario and future applicability of antivirals against herpes zoster
Sang Hun Kim
The Korean journal of pain (2022) Vol. 36, Iss. 1, pp. 4-10
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top